V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011101 | 280011901 | 1.7 | 80.6 | Palliative (P) | 2018-07-21 | 2018-07-25 | Paclitaxel 80mg/m2 day 1 8 15 | Y | N | 280025997 | PACLITAXEL |
| 280011102 | 280005247 | null | 61.5 | Curative (C) | null | 2017-03-23 | Cisplatin | N | Y | 280026014 | CISPLATIN |
| 280011103 | 280005254 | 1.8 | null | Neo-adjuvant (N) | 2016-08-06 | 2016-08-09 | Cetuximab + Radiotherapy Load | 02 | Y | 280026030 | CETUXIMAB + RT |
| 280011104 | 280005261 | 1.52 | 72 | Palliative (P) | 2019-05-30 | 2019-06-19 | CETUXIMAB + RT | N | N | 280026046 | CETUXIMAB + RT |
| 280011105 | 280008781 | 0 | 79.5 | Disease modification (D) | 2018-03-20 | 2018-03-20 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280026065 | RMS 2005 TRIAL |
| 280011106 | 280005273 | 1.61 | 75.1 | Palliative (P) | null | 2018-02-22 | DOXORUBICIN | N | N | 280026074 | DOXORUBICIN |
| 280011107 | 280005276 | 1.7 | null | Curative (C) | 2017-04-22 | 2017-05-06 | Cetuximab + Radiotherapy Maint | N | N | 280026078 | CETUXIMAB + RT |
| 280011108 | 280005287 | null | 90.9 | Palliative (P) | 2015-05-26 | 2015-06-15 | DOXORUBICIN | null | null | 280026121 | DOXORUBICIN |
| 280011109 | 280008795 | 1.8 | 100.9 | null | 2017-01-25 | 2017-03-01 | Cetuximab + Radiotherapy Maint | N | Y | 280026163 | CETUXIMAB + RT |
| 280011110 | 280005306 | 1.8 | 114 | Palliative (P) | 2017-08-18 | 2017-09-05 | Cetuximab + Radiotherapy Maint | N | N | 280026195 | CETUXIMAB + RT |
| 280011111 | 280005313 | null | 102.95 | Curative (C) | 2013-05-12 | 2013-09-02 | CARBOPLATIN + RT | N | Y | 280026220 | CARBOPLATIN + RT |
| 280011112 | 280005317 | 1.82 | null | Palliative (P) | null | 2014-07-02 | Cetuximab + Radiotherapy Maint | null | Y | 280026223 | CETUXIMAB + RT |
| 280011113 | 280005327 | 1.61 | 72 | Curative (C) | 2016-11-05 | 2017-03-13 | CARBOPLATIN + RT | N | N | 280026247 | CARBOPLATIN + RT |
| 280011114 | 280008806 | 1.56 | 12.7 | Palliative (P) | 2015-02-27 | 2015-03-13 | Ifosfamide | N | null | 280026259 | IFOSFAMIDE |
| 280011115 | 280005337 | 1.63 | 38.4 | Adjuvant (A) | 2015-01-17 | 2015-03-21 | CARBOPLATIN + RT | Y | N | 280026282 | CARBOPLATIN + RT |
| 280011116 | 280008811 | 1.7 | null | Palliative (P) | 2017-12-23 | 2017-12-23 | Doxorubicin 75mg/m2 | 02 | N | 280026292 | DOXORUBICIN |
| 280011117 | 280005340 | 1.62 | 100 | Palliative (P) | 2014-12-16 | 2014-12-16 | CETUXIMAB + RT | null | null | 280026309 | CETUXIMAB + RT |
| 280011118 | 280008813 | 0 | 59.6 | Neo-adjuvant (N) | 2017-08-14 | 2017-10-24 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280026313 | RMS 2005 TRIAL |
| 280011119 | 280005350 | 1.81 | 72.6 | Palliative (P) | 2016-05-06 | 2016-05-20 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026319 | RMS 2005 TRIAL |
| 280011120 | 280008817 | 1.72 | 57.2 | Palliative (P) | 2014-09-25 | 2014-10-16 | CETUXIMAB + RT | 02 | N | 280026333 | CETUXIMAB + RT |
| 280011121 | 280005356 | 1.81 | null | Palliative (P) | null | 2017-11-18 | Cetuximab + Radiotherapy Maint | N | N | 280026342 | CETUXIMAB + RT |
| 280011122 | 280005361 | 1.81 | null | Palliative (P) | 2018-07-19 | 2018-07-19 | Ifosfamide | 02 | N | 280026352 | IFOSFAMIDE |
| 280011123 | 280005368 | 1.8 | 95.3 | Palliative (P) | 2015-12-29 | 2016-03-15 | Cisplatin 7 day | 02 | Y | 280026392 | CISPLATIN |
| 280011124 | 280005372 | 1.62 | 44.2 | Adjuvant (A) | 2015-12-07 | 2015-12-07 | Cetuximab + Radiotherapy Maint | N | Y | 280026402 | CETUXIMAB + RT |
| 280011125 | 280005381 | 1.62 | 131 | Palliative (P) | 2015-08-24 | 2015-08-25 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026482 | PACLITAXEL |
| 280011126 | 280005383 | 1.78 | 73 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-23 | DOXORUBICIN | 01 | N | 280026486 | DOXORUBICIN |
| 280011127 | 280008834 | 0 | 16.1 | Palliative (P) | 2017-04-21 | 2017-12-19 | Ifosfamide PVI 1g/m2 14day | N | N | 280026519 | IFOSFAMIDE |
| 280011128 | 280005389 | 0 | 66.9 | Neo-adjuvant (N) | 2017-01-29 | 2017-04-24 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | 280026547 | IVA |
| 280011129 | 280011307 | 1.6 | 65 | Palliative (P) | null | 2017-04-08 | Cetuximab + Radiotherapy Maint | N | Y | 280026571 | CETUXIMAB + RT |
| 280011130 | 280011307 | 0 | null | Curative (C) | 2016-05-02 | 2016-06-16 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026571 | RMS 2005 TRIAL |
| 280011131 | 280005404 | 1.8 | null | Curative (C) | 2017-04-02 | 2017-04-15 | Cisplatin | N | N | 280026673 | CISPLATIN |
| 280011132 | 280005408 | 1.7 | 84.8 | Palliative (P) | 2015-10-22 | 2015-10-29 | CETUXIMAB + RT | 02 | Y | 280026700 | CETUXIMAB + RT |
| 280011133 | 280005411 | 0.84 | 89 | Curative (C) | 2014-12-22 | 2014-12-23 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026704 | RMS 2005 TRIAL |
| 280011134 | 280005418 | 1.86 | 60.6 | Neo-adjuvant (N) | 2017-12-01 | 2017-12-02 | Paclitaxel 7 day | null | null | 280026722 | PACLITAXEL |
| 280011135 | 280005420 | 1.78 | 75.1 | Palliative (P) | 2015-06-10 | 2015-08-31 | Cisplatin | 02 | Y | 280026724 | CISPLATIN |
| 280011136 | 280008857 | 1.57 | null | Palliative (P) | 2017-12-18 | 2018-01-02 | Doxorubicin 75mg/m2 | null | null | 280026746 | DOXORUBICIN |
| 280011137 | 280005428 | 1.83 | null | Adjuvant (A) | 2018-02-11 | 2018-09-30 | CARBOPLATIN + RT | 2 | Y | 280026758 | CARBOPLATIN + RT |
| 280011138 | 280005434 | 1.9 | 14 | Palliative (P) | 2015-02-15 | 2015-03-03 | Cetuximab + Radiotherapy Maint | 02 | N | 280026793 | CETUXIMAB + RT |
| 280011139 | 280005435 | 1.54 | 69.5 | Palliative (P) | 2018-04-28 | 2018-06-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026799 | PACLITAXEL |
| 280011140 | 280005437 | 1.69 | 82.5 | null | 2014-06-26 | 2014-11-11 | CETUXIMAB + RT | N | N | 280026803 | CETUXIMAB + RT |
| 280011141 | 280012013 | 1.6 | null | Neo-adjuvant (N) | 2014-11-18 | 2015-01-16 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026811 | IVA |
| 280011142 | 280005452 | 1.51 | 60.5 | Neo-adjuvant (N) | null | 2013-08-13 | DOXORUBICIN | N | N | 280026839 | DOXORUBICIN |
| 280011143 | 280005454 | null | 72.6 | null | 2016-02-06 | 2016-03-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280026865 | PACLITAXEL |
| 280011144 | 280005455 | 1.82 | 116 | Palliative (P) | 2017-09-30 | 2018-01-01 | Cisplatin 7 day | null | null | 280026889 | CISPLATIN |
| 280011145 | 280005461 | null | 81 | null | 2014-09-26 | 2014-10-20 | Cetuximab + Radiotherapy Maint | N | Y | 280026893 | CETUXIMAB + RT |
| 280011146 | 280005463 | 1.54 | 18.3 | null | 2014-12-16 | 2015-02-14 | IVA | null | N | 280026900 | IVA |
| 280011147 | 280008877 | 0.98 | 90.75 | Not known (9) | 2014-05-23 | 2014-05-23 | STS Rhabdomyosarcoma RMS 2005 IVA | 1 | N | 280026902 | IVA |
| 280011148 | 280005473 | 1.82 | null | Palliative (P) | 2016-05-14 | 2016-05-21 | Cetuximab + Radiotherapy Maint | null | null | 280026919 | CETUXIMAB + RT |
| 280011149 | 280005476 | 1.82 | 95 | Curative (C) | 2016-01-01 | 2016-01-18 | CETUXIMAB + RT | N | N | 280026921 | CETUXIMAB + RT |
| 280011150 | 280005478 | 1.6 | 42 | Palliative (P) | 2014-06-07 | 2014-06-21 | Cetuximab + Radiotherapy Maint | N | N | 280026932 | CETUXIMAB + RT |